These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. CXC chemokines in angiogenesis of cancer. Strieter RM; Belperio JA; Phillips RJ; Keane MP Semin Cancer Biol; 2004 Jun; 14(3):195-200. PubMed ID: 15246055 [TBL] [Abstract][Full Text] [Related]
6. CXC chemokines and angiogenesis/angiostasis. Keane MP; Arenberg DA; Moore BB; Addison CL; Strieter RM Proc Assoc Am Physicians; 1998; 110(4):288-96. PubMed ID: 9686676 [TBL] [Abstract][Full Text] [Related]
7. The role of CXC chemokines and their receptors in cancer. Vandercappellen J; Van Damme J; Struyf S Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287 [TBL] [Abstract][Full Text] [Related]
8. CXC chemokines: the regulatory link between inflammation and angiogenesis. Romagnani P; Lasagni L; Annunziato F; Serio M; Romagnani S Trends Immunol; 2004 Apr; 25(4):201-9. PubMed ID: 15039047 [No Abstract] [Full Text] [Related]
9. Understanding the immunoangiostatic CXC chemokine network. Balestrieri ML; Balestrieri A; Mancini FP; Napoli C Cardiovasc Res; 2008 May; 78(2):250-6. PubMed ID: 18252760 [TBL] [Abstract][Full Text] [Related]
10. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061 [TBL] [Abstract][Full Text] [Related]
11. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy. Fall N; Bove KE; Stringer K; Lovell DJ; Brunner HI; Weiss J; Higgins GC; Bowyer SL; Graham TB; Thornton S; Grom AA Arthritis Rheum; 2005 Oct; 52(10):3175-80. PubMed ID: 16200621 [TBL] [Abstract][Full Text] [Related]
12. The role of CXC chemokines as regulators of angiogenesis. Strieter RM; Polverini PJ; Arenberg DA; Kunkel SL Shock; 1995 Sep; 4(3):155-60. PubMed ID: 8574748 [TBL] [Abstract][Full Text] [Related]
13. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. Moore BB; Keane MP; Addison CL; Arenberg DA; Strieter RM J Investig Med; 1998 Apr; 46(4):113-20. PubMed ID: 9635369 [No Abstract] [Full Text] [Related]
14. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer. Strieter RM; Belperio JA; Burdick MD; Sharma S; Dubinett SM; Keane MP Ann N Y Acad Sci; 2004 Dec; 1028():351-60. PubMed ID: 15650260 [TBL] [Abstract][Full Text] [Related]
15. The chemokine system -- a major regulator of angiogenesis in health and disease. Rosenkilde MM; Schwartz TW APMIS; 2004; 112(7-8):481-95. PubMed ID: 15563311 [TBL] [Abstract][Full Text] [Related]
16. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. Strieter RM; Polverini PJ; Kunkel SL; Arenberg DA; Burdick MD; Kasper J; Dzuiba J; Van Damme J; Walz A; Marriott D J Biol Chem; 1995 Nov; 270(45):27348-57. PubMed ID: 7592998 [TBL] [Abstract][Full Text] [Related]
17. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046 [TBL] [Abstract][Full Text] [Related]